14 15 16 Highlights 17  Enhancer ChIP-seq of cortical subregions reveals 59372 putative enhancers. 18
SUMMARY 23
Understanding neural circuit function requires individually addressing their component parts: specific neuronal cell 24 types. However, not only do the precise genetic mechanisms specifying neuronal cell types remain obscure, access to 25 these neuronal cell types by transgenic techniques also remains elusive. While most genes are expressed in the brain, 26 the vast majority are expressed in many different kinds of neurons, suggesting that promoters alone are not sufficiently 27 specific to distinguish cell types. However, there are orders of magnitude more distal genetic cis-regulatory elements 28 controlling transcription (i.e. enhancers), so we screened for enhancer activity in microdissected samples of mouse 29 cortical subregions. This identified thousands of novel putative enhancers, many unique to particular cortical 30 subregions. Pronuclear injection of expression constructs containing such region-specific enhancers resulted in 31 transgenic lines driving expression in distinct sets of cells specifically in the targeted cortical subregions, even though 32 the parent gene's promoter was relatively nonspecific. These data showcase the promise of utilizing the genetic 33 mechanisms underlying the specification of diverse neuronal cell types for the development of genetic tools potentially 34 capable of targeting any neuronal circuit of interest, an approach we call Enhancer-Driven Gene Expression (EDGE) . 35
The mammalian brain is arguably the most complex biological structure known, composed of around 10 11 neurons in 42 humans [1] . While this number is generally accepted, the same is not true for how many different kinds of neurons exist. 43
Indeed, there is not even a clear consensus as to how to define a neuronal cell type: by morphology, connectivity, gene 44 expression, receptive field type, or some combination of the above? If one takes the expansive view (i.e. all of the 45 above), the numbers quickly become astronomical. For example, current estimates of retinal cell types range between 46 100 and 150 [2] , and dozens of cell types have been proposed for a single hypothalamic area based solely on which 47 genes are expressed [3] . However, gene expression alone is a poor basis for defining cell types, because although most 48 genes are expressed in the adult brain, the vast majority of them are expressed in many different cell types [4] . 49
Identification of neuronal cell types is much more than an issue of taxonomy, it is crucial to understanding brain 50 function. The past two decades have seen the development of revolutionary molecular tools which allow one to 51 determine the precise connectivity of neurons [5, 6] as well as manipulate [7] [8] [9] and observe[10] their activity. Yet, the 52 utility of these powerful tools is often limited by the inability to deliver them at the level of particular neuronal cell 53 types. Almost all existing neuron-specific lines are either made by non-homologous recombination of minimal promoter 54 modifications H3K27ac and H3K4me2 for samples of each of the four brain regions. The regions enriched for H3K27ac 79
reproducibly identified similar numbers of active promoters and distal cis-regulatory sequences between two replicates 80 of each brain subregion (Figure 2A ). Nearly 90% of all active promoters were identified in at least two subregions with 81 the remainder being active in only one subregion (17032 total, 2045 unique) . 82
When we analyzed more distal sites (>5kb from a transcriptional start site) we identified a total of 59372 reproducibly 83 active enhancers in at least one subregion. Of these 31% were only identified in a single cortical subregion (18185 84 unique relative to other subregions). Surprisingly the number of subregion specific enhancers in the cortex was similar 85 to the number of total enhancers active in any single tissue in the body thus far investigated [20, 27] . Furthermore, 81% 86 (48077) of enhancers identified in these subregions were not identified in bulk cortex tissue, presumably due to signal-87 to-noise ratios. The fact that so many novel and unique enhancers were isolated from a tiny minority of cortical regions 88 demonstrates the potentially vast repertoire of enhancers active in the brain. 89
Interestingly, when comparing the total number of reproducible peak calls in these 4 cortical subregions (59372) to the 90 number identified in bulk cortex treated in the same way (13472), the number of putative active enhancers one obtains 91 from the four cortical subregions is far greater than what one obtains from the entire cortex, even though these four 92 cortical regions compose only a small minority of the entire cortex. Of course, this is comparing 4 pooled samples to a 93 single sample, but each of the individual samples gives numbers similar to bulk cortex ( Figure 2 ). In our view, the most 94 likely explanation for this superficially puzzling result is a reduction in signal to noise ratio when pooling heterogeneous 95 sets of tissues for ChIP-seq. This would tend to favor those enhancers that are expressed throughout many cortical 96 subregions at the expense of more specific ones. In support of this, 89% of cortical enhancers were found in one or 97 6 more cortical subregions, and 78% were found in at least 2 cortical subregions. Compare this to the fact that fully 31% 98 of the enhancers we found in our subregions were specific to that single subregion. 99 While many of these enhancers identified by peak calls alone are specific to this small number of cortical subregions 100 the goal of this study was to identify very specific regulatory sequences with limited activity within other regions of the 101 brain as well as the rest of the body. To ensure the identification of such sequences and exclude regions with weak 102 activity elsewhere we expanded our comparisons to include a variety of published mouse adult tissues and cultured cell 103 types [27] . We first identified active putative enhancers in these additional mouse samples and merged them to create 104 a unified set of enhancers for consistent comparisons across all samples. We then extracted normalized H3K27ac counts 105 at 108299 discrete regions from the subregions profiled in this study as well as those from 17 mouse ENCODE 106 samples [27] . Hierarchical clustering of samples revealed two main groups of mouse tissues: neuronal and non-neuronal 107 ( Figure 2B ). Amongst non-neuronal tissues, the strongest correlations were observed in developmental stages of heart 108 and tissues that make up the immune system: bone marrow, thymus, and spleen. In neuronal tissues the four cortical 109 subregions profiled here were well correlated across all enhancers assayed but clustered distinctly from cerebellum, 110 olfactory bulb, and embryonic brain. 111
We then utilized k-means clustering to identify enhancers that were significantly more active in each cortical region 112 versus each other ( Figure 2C ) and the other 17 mouse tissues. Those enhancers that were identified as most specifically 113 active in a given cortical subregion were then further filtered to ensure that they were never identified by peak calling 114 in any other mouse tissue. Even though this does not exclude identification of enhancers as unique while they are 115 actually highly enriched, it does increase the specificity and thus the chances of identifying unique enhancers. This 116 stringent analysis yielded 165 to 1824 novel and unique putative distal enhancers for each cortical subregion ( Figure  117 2C, Data S1). We then assigned these novel enhancers to putative target genes based upon the GREAT algorithm [28] . 118
Gene ontology analysis suggests these novel enhancers are enriched near genes associated with a variety of neuronal 119 functions ( Figure S2 ). We prioritized these novel putative enhancers based on specificity of the H3K27ac signal relative 120 to other regions and conservation across 30 species. We then cloned a subset of them specific to the entorhinal cortices 121 (EC) upstream of a heterologous minimal promoter driving the tetracycline transactivator (tTA[29]) for transgenesis 122 ( Figure S3 ). 123 7 Region-specific enhancers drive transgene expression in targeted cortical subregions
124
Of course, just because a sequence is identified by ChIP-seq does not mean that it is a valid enhancer, let alone that it 125 can drive region-or cell type-specific transgene expression. Even a single case of expression in a particular tissue type 126
is not sufficient because one can obtain specific transgene expression by randomly inserting a minimal 127 promoter/reporter construct into the genome. This technique is known as an "enhancer trap" because it relies upon 128 random insertion near a native enhancer to drive the transgene expression [12, 30] . To ensure that the expression 129 pattern comes from the enhancer construct and not from the insertion site, the standard way to validate a putative 130 enhancer is to show that at least three distinct transgenic embryos (with three distinct random insertion sites) have 131 similar expression patterns [26] . We therefore injected enough oocytes to get at least three genotypically-positive 132 founders for each putative enhancer construct. But, since our aim was to generate modular genetic tools rather than 133 simply to validate the enhancers, we could not sacrifice the founders to validate the enhancer as is typically done. 134
Instead, the founders were crossed to tTA dependent reporter mice for visualization of expression patterns. 135
We selected 8 (notionally) MEC-specific and 2 LEC-specific enhancers for transgenesis. Transgenesis via pronuclear 136 injection is not an efficient process because it involves random integration into the genome. While one typically only 137 publishes the ones that work, it is worth specifying what issues have to do with transgenesis in general versus using 138 EDGE. When making any transgenic line, some founders do not successfully transmit the transgene to offspring, while 139 others fail to express presumably due to negative insertional (a.k.a. positional) effects. For these reasons, only 45 lines 140 derived from 105 genotypically-positive founders expressed in the brain when mated to a tetO reporter line, a number 141 that is typical regardless of the injection construct. Notably, nearly all of them (41) expressed the reporter in the EC, 142
including at least one from each of the 10 enhancer constructs ( Figure S4 and Table S1 ). Since an enhancer trap would 143 lead to random expression patterns, this alone suggests that the specificity of expression comes from the transgenic 144 enhancer. At least as compelling is the fact that when we obtained multiple distinct founders with a given enhancer 145 construct, almost all of them had similar expression patterns (see Figure S5 for examples). 146 Figure 3A shows an example of the results of our bioinformatic analysis for one of the eight MEC enhancers 81, see methods for nomenclature) which GREAT associated with the gene Kitl. Note that the promoter region (vertical 148 yellow band) is a strong peak in all brain regions, consistent with expression of the Kitl mRNA throughout the brain 149 ( Figure 3B ). The same is true for other putative enhancers (horizontal black bars). In contrast, the downstream enhancer 150 8 peak used for transgenesis (MEC-13-81, Figure 3A blow-up), while not as strong as some of the other peak calls, is 151 greatly enriched in MEC. Figure 3C shows the result of crossing the transgenic line MEC-13-81B to an tetO-ArChT 152 payload line [31] . Remarkably, even though the Kitl promoter expresses throughout the brain (including multiple layers 153 of the EC, Figure 3B ), the tetO-ArChT payload is confined to layer II of MEC ( Figure 3C ). In other words, one can obtain 154 highly specific targeted gene expression from regionally specific cis-elements of non-specific genes. 155
The same basic result of highly specific expression from single enhancers of non-specific genes was also true for 4/8 156 MEC-and 2/2 LEC-specific enhancer constructs we injected, although the correspondence between the ChIP-seq signal 157 and the expression was not always as tight. Figure 4 compares the expression patterns of representative transgenic 158 driver lines made with other injection constructs containing either MEC-specific enhancers ( Figure 4A to 4C, right 159 column) or LEC-specific enhancers ( Figure 4D and E, right panel. Extended medial-lateral of sections range in Figure S4A -160 F) compared to the expression pattern of the presumed associated native gene (Figure 4 left column). Note that while 161 each associated gene is broadly expressed in the brain, the transgenic lines all express more or less specifically in the 162 brain region the enhancers were isolated from. When crossed with broadly expressing tTA lines (such as CaMKIIa [11]), 163 these tetO payload lines express broadly (see references for published lines and Figure S6 for our as-of-yet unpublished 164 tetO-GCaMP6 line). These data show that one can obtain targeted region-specific (and possibly even cell type-specific) 165 expression from elements of a non-specific promoter by using one of its region-specific enhancer to drive a 166 heterologous core promoter. Even those enhancers that were less specific still gave rise to lines that were enriched in 167 the EC relative to the expression of the native gene ( Figure S4G -J). This in effect solves the problem that most genes 168 are expressed in multiple cell types in the brain: using EDGE one can dissect out the individual genetic components 169 which underlie the expression of a "nonspecific" gene in multiple cell types. 170
Region versus cell type-specific expression?
171
The above results show that subregion specific expression can result from subregion specific enhancers. Whether such 172 enhancers drive expression in specific cell types in the targeted brain region is a more difficult question to answer, in 173 large part because there is no consensus as to the number of cell types in the brain or how to classify them. However, 174 there are indications that some these enhancers can specify particular cell types, at least to the level of granularity 175 current knowledge permits. First, the different EC enhancers tend to drive expression in different layers of the EC ( Figure  176 9 some of these enhancers are clearly not cell type-specific ( Figure S4G -J). Since four of the enhancers drive expression 178 in layer II, this raises the question of whether they specify the same cell type, or distinct biological subpopulations. We 179 therefore investigated the expression of immunohistochemical markers used to characterize cell types of EC in two layer 180 II expressing lines derived from MEC-specific enhancers ( Figures 5A, B and 6A, B) . The underlying logic is that if the two 181 distinct enhancers drive transgene expression in subsets of the exact same cell type(s), they should both express the 182 same proportions of neurochemical markers. Neither of the two enhancers appear to drive expression in inhibitory 183 neurons ( Figure 5I -L and 6I-L), so the question becomes whether they express in different types of excitatory neurons. 184
Excitatory neurons in EC layer II are typically further subdivided into reelin positive cells and calbindin positive cells [32] . 185
Line MEC-13-53A expressed exclusively in reelin+ neurons ( Figure 5C -H, L), while line MEC-13-104B roughly corresponds 186 to the relative densities of the two celltypes ( Figure 6C -H, L). Thus it appears that MEC-13-53A is a stellate cell specific 187 enhancer, whereas MEC-13-104B is found in both neurochemical kinds of excitatory cells of layer II described to date. 188
This means that some enhancers specify different subsets of cells even within a single cortical layer, showing the 189 potential of enhancers to distinguish between cell types with a finer granularity than possible with native promoters. Of 190 course, the functional significance, if any, of these subsets of cells remains to be demonstrated. 192 We demonstrate the existence of thousands of previously undescribed putative enhancers uniquely active in targeted 193 cortical subregions of the adult mouse brain. We took a small subset (10/3740) of the enhancers that were specific to 194 the EC and combined them with a heterologous minimal promoter to make transgenic mice expressing the tTA 195 transactivator. When crossed to tetO payload lines, we obtained transgene expression specific to the EC, and possibly 196 even particular cell types in the targeted region. The genes that these enhancers (presumably) act upon are nowhere 197 near that specific. Most genes express in multiple cell types in the brain. Since there are only around 24.000 genes (and 198 around 46.000 promoters [19] ), but estimated millions of putative enhancers [19, 20] , this implies that the same gene is 199 expressed in different cell types by using different sets of enhancers acting upon the same promoter. In turn, this 200 suggests that there may be a genetic diversity in the brain beyond most estimates of the number of distinct neuronal 201 cell types in the cortex [33] [34] [35] [36] . Moreover, this provides a strategy to make genetic tools with far greater cell type and 202 regional specificity of expression than promoter-based methods, by far the dominant means to generate neuron specific 203 transgenic animals to date. 204 EDGE is a method to create neuron-specific tools for targeted brain regions novel about what has been presented here. A variety of forms of enhancer ChIP-seq have existed for roughly a 207 decade [22, 26] , and the general concept that the same gene is expressed in different tissues by the use of different 208 enhancers is even older [30] . Hundreds of thousands of putative enhancers have already been identified in the mouse 209 genome by dissection of distinct tissues (including cortex) followed by ChIP-seq [20, 27] . Indeed, a molecular geneticist 210 in the transcription field may find the results presented here unsurprising, as generation of a transgenic animal is how 211 putative enhancers are biologically verified, although the transgenic founders are typically killed in the process [22, 25, 212 26, 37] . In short, we have not invented any novel techniques, but we demonstrate how the application of these existing 213 technologies to the adult brain could potentially provide systems neuroscientists with a means to make cell type-specific 214 tools for any brain region of interest, greatly facilitating the study of the functional circuitry of the adult brain. 215 diversity of enhancers. One group has performed ChIP-seq on 136 different dissected human brain regions, obtaining 218 over 80.000 putative enhancers [38] . Another group has used ATAC-seq to profile open chromatin in transgenically-219 defined excitatory cells from different layers of the mouse visual cortex [39] . They found a diversity of putative cis-acting 220 sequences even within single layers of a single type of cortex, implying distinct classes of cells. Finally, using single cell 221 methylomes, Luo et al. have shown that neuron type classification is supported by the epigenomic state of regulatory 222 sequences [40] . Nonetheless, in none of these cases were these putative enhancers biologically verified, nor used to 223 make molecular genetic tools, which is the point of this paper. 224
10

DISCUSSION
Conversely, many enhancers derived from the developing brain have in fact been biologically verified, and even used to 225 make transgenic lines and viruses [41] . Evolutionarily conserved single enhancers demonstrably label specific subsets of 226 cells during development [25, 26, 37, 42] , with different subsets active in different developmental epochs [43] . Of 227 particular interest is a pair of papers from the Rubenstein lab examining the activity of enhancers derived from the 228 developing (E11.5) telencephalon. They made CreER lines from the pallium (14 lines [44] ) and subpallium (10 lines [45] ) 229
to illustrate the fatemaps of the telencephalic subdivisions by comparing expression patterns at several timepoints 230 during development and young adulthood. By examining in vivo transcription factor occupancy they showed that 231 broadly expressed transcription factors interact with far more specific enhancer elements [44] . 232
Taken together, all these studies provide part of the basis for what is presented here. However, their focus was on the 233 transcriptional and developmental mechanisms of neural cell fate relatively early in development. As these and other 234 studies demonstrated, every neuroepithelial cell present at this time will have many daughter cells which will further 235 differentiate during development into many more neuronal and non-neuronal (e.g. glia) cell types [46, 47] . Presumably, 236 for this reason, these enhancers show relatively broad expression in the adult brain [45] . Subpallial enhancers as 237 expected tended to drive expression in GABAergic cells, but do not distinguish between the various known subtypes of 238
GABAergic interneurons [41, 48] . Therefore, although these tools are valuable to the elucidation of cell lineages, they 239 are not necessarily more specific than promoter-based transgenic lines [15] , which as noted earlier are not always 240 specific enough for the analysis of native neural circuits. 241
Thus, a seemingly trivial difference in technique results in a large increase in utility for systems neuroscience. Applying 242 the same methods discussed above to microdissected adult cortical subregions allows one to make molecular genetic 243 tools apparently specific to particular cell types of the targeted brain regions. The microdissection is not in fact a trivial 244 feature: by examining four subregions of the cortex separately, we found around four times as many reproducible peak 245 calls as was obtained from the entire cortex [27] , even though these four subregions together comprise a small minority 246 of the cortex. This implies that individual cortical subregions contain their own epigenetically distinct cell types, which 247 are washed out when pooled. Similarly, there is relatively little overlap between the enhancers active in the embryonic 248 brain and those we have obtained from adult brain ( Figure 2 ). Hence, it would be interesting to work backwards and 249 study the developmental expression of EDGE lines made from subdivisions of the adult brain to investigate the genetic 250 signatures of the pre-and postnatal processes that specify the enormous variety of neuronal cell types present in the 251 fully differentiated adult brain. In sum, we do not claim to have discovered anything novel about transcription in the 252 brain, although the sheer number of novel putative enhancers unique to particular cortical subregions was surprising, 253 nor the methods described herein. What we claim is both novel and significant is the application of these methods to 254 the generation of anatomically-specific tools enabling the study of the circuit dynamics of the adult brain [49] . 255
It is worth mentioning that EDGE is not the same as enhancer traps. In enhancer traps [12, 30] , one randomly inserts a 256 minimal promoter construct into the genome in the hopes of integrating near a specific enhancer while EDGE involves 257 the identification and use of enhancers specific to particular brain regions. The key advantage of EDGE over enhancer 258 traps is anatomical targeting. To illustrate, we can compare our results to those of a recently published enhancer trap 259 study[12] using a lentiviral vector containing the exact same minimal promoter we used. Since we are interested in the 260 EC, we consider the creation of EC specific lines the goal, as in the current study. The total number of genotypically 261 positive founders that express in the brain are similar (45/105: 43% herein vs. 42/151: 28%), and both techniques can 262 yield very specific expression patterns. The key difference is the numbers of lines expressing in the EC at all (41/45: 91% 263 herein vs. 6/42: 14%) and especially those more or less specifically expressing in the EC (16/45: 36% vs. 0/42: 0%). This 264 illustrates the difference between the two approaches: enhancer traps result in expression in random cell types 265 throughout the brain (and indeed the entire body), while EDGE targets those cell types found in particular brain regions 266 of interest. 267
Of course, not everyone is interested in the EC. While we subtracted out any enhancers which expressed anywhere but 268 the MEC (or LEC), other investigators interested in other brain regions can use the same strategy to develop tools 269 specifically targeting their brain regions of interest. This process can occur for any brain regions, potentially providing 270 cell type-specific tools to interrogate any neural circuit. Moreover, the more subdivisions of the brain one collects, the 271 13 more one can subtract, so therefore the more specific the resulting putative enhancers will be. With this in mind we 272 have initiated a second round of enhancer ChIP-seq with over 20 brain subregions which will provide a much more 273 generally useful resource. Finally, the relatively small size of the enhancers means they can fit easily in viral vectors. If 274 EDGE viruses recapitulate the anatomical specificity seen in transgenic mice, this will potentially bring EDGE to bear on 275 any species [41] . This could revolutionize not only systems neuroscience, but ultimately provide a novel therapeutic 276 avenue to rectify the circuit imbalances that underlie disorders of the central nervous system. 277
Do enhancers specify neuronal cell types in the brain?
278
One of the most interesting questions in neuroscience is how we should think about the 100 or so billion neurons in our 279 brains-as unique actors, or as repeated elements in a printed circuit? The answer is likely in between. Several 280 investigators have proposed a canonical circuit for the neocortex[50, 51] , with regional variations, and there are clearly 281 commonalities in neocortical circuits, particularly with regards to layer-specific connectivity. Yet, within this general 282 canonical theme there are uniquely specialized cell types in individual cortical subregions. Our results demonstrate that 283 there are thousands of putative enhancers unique to cortical subregions, a number far larger than the number of genes 284 that are specific to these subregions (indeed to our knowledge there are no EC specific genes). Why do the same genes 285 use different enhancers to express in different cortical subregions? There is not yet enough data for a satisfactory 286 answer, but the developmental literature discussed above would suggest a combinatorial code of transcription factors 287 and active enhancers for each unique cell fate. If so, enhancer usage could provide a finer grained differentiation of cell 288 type than gene expression alone. The fact that there are hundreds to thousands of unique enhancers in individual 289 cortical subregions means that the genetic machinery exists to have a similar number of differentiable cell types. In 290 support of this, a recent study of the transcriptome of thousands of individually sequenced neurons from two different 291 cortical regions finds a large number of distinct transcriptional profiles between excitatory, but not inhibitory 292 neurons [52] . This (as well as the fact that inhibitory neurons are a small minority of cortical neurons) may explain why 293 we only obtained expression in excitatory neurons when we selected region-specific enhancers. There are two possible explanations for this is the first one being that these distinct enhancers drive expression in 299 functionally distinct subsets of stellate cells [52, 53] . The other, possibility is that each enhancer drives expression in 300 stellate cells as part of a co-regulated network of enhancers specifying this cell type [38] . If so, the difference in 301 percentage of expression in stellate cells is largely artefactual, resulting from differential penetrance of transgene 302 expression of otherwise identical cells due to mosaicism arising from insertional effects. The exhaustive biochemical, 303 anatomical and electrophysiological characterization of each line necessary to provide a definitive answer to the 304 relationship between these enhancers and cell types is beyond the scope of this paper. However, the fact that there are 305 so many enhancers unique to specific cortical subregions implies the potential for a more direct connection between 306 the molecular identity of a cell and cell type in other terms. Moreover, it is entirely possible that further subdivisions of 307 the cells specified by these transgenic lines could provide even more specific expression. This could be achieved in a 308 variety of ways, for example by finer manual microdissection, laser capture microscopy or even nested ChIP-seq of 309 transgenically-labeled cells isolated by a cell sorter from microdissected tissue. 310
Regardless, our results certainly do not suggest that every enhancer defines a distinct cell type, in fact several of our 311 lines express in more than one layer. There is not necessarily a one-to-one correspondence between cell types and 312 enhancers: a single cell type could be specified by multiple unique enhancers, i.e. a co-regulated enhancer network [38] . 313
Conversely, different cell types may arise from distinct combinatorial codes of active enhancers, meaning the number 314 of different cell types may conceivably be even larger than the number of unique enhancers. Finally, there are other 315 reasons for differential sets of active enhancers beyond definition of cell type: neural activity changes the chromatin 316 landscape [54] . This means that activity of differential enhancers does not automatically imply different cell types but 317 changes in function of a given cell. Nevertheless, differential enhancer utilization does signify distinct epigenetic 318 signatures, even if their functional significance is currently unclear. We therefore maintain that a powerful way to 319 investigate the relationship of diverse cis-acting elements of the genome to the functional circuitry of the brain is to 320 create and study enhancer-specific tools like those presented here. 
24.
Visel, A., Taher, L., Girgis, H., May, D., Golonzhka, O., Hoch, R.V., McKinsey, G.L., Pattabiraman, K., Silberberg, 391 S.N., Blow, M.J., et al. (2013) . A high-resolution enhancer atlas of the developing telencephalon. Cell 152, 895-392 908. 393 25. Cotney, J., Leng, J., Yin, J., Reilly, S.K., DeMare, L.E., Emera, D., Ayoub, A.E., Rakic, P., and Noonan, J.P. (2013). 394
The evolution of lineage-specific regulatory activities in the human embryonic limb. Lansu, N., Meunier, C., et al. (2014) . Large-scale identification of coregulated enhancer networks in the adult 425 human brain. Cell Rep 9, [767] [768] [769] [770] [771] [772] [773] [774] [775] [776] [777] [778] [779] 39. Gray, L.T., Yao, Z., Nguyen, T.N., Kim, T.K., Zeng, H., and Tasic, B. (2017) . Layer-specific chromatin accessibility 427 landscapes reveal regulatory networks in adult mouse visual cortex. Elife 6. 428 40. Luo, C., Keown, C.L., Kurihara, L., Zhou, J., He, Y., Li, J., Castanon, R., Lucero, J., Nery, J.R., Sandoval, J.P., et al. 429 (2017 Silberberg, S.N., Taher, L., Lindtner, S., Sandberg, M., Nord, A.S., Vogt, D., McKinsey, G.L., Hoch, R., 444 Pattabiraman, K., Zhang, D., et al. (2016) Siepel, A., Bejerano, G., Pedersen, J.S., Hinrichs, A.S., Hou, M., Rosenbloom, K., Clawson, H., Spieth, J., Hillier, 498 L.W., Richards, S., et al. (2005) . Evolutionarily conserved elements in vertebrate, insect, worm, and yeast 499 genomes. in the blow-up to the right. See also Figure S3 , S4, S5, S6 and Table S1 . 535 23 536 Enhancer-Driven Gene Expression: a single active enhancer isolated from a particular brain region drives transgene 572 expression from a heterologous minimal promoter (blue). This leads to transgene expression that is restricted to a 573 particular region-specific subset of the cell types that the native promoter expresses in, greatly increasing the 574 anatomical specificity relative to promoter-based methods or the native gene. architectonic criteria [55-59] to unstained tissue. The tissue samples were snap-frozen in liquid nitrogen, kept at -80 0 C 600 and shipped on dry ice. 601
All dissections avoided border regions (i.e., centered in the identified cortical area). In horizontal sections, MEC is easily 602 recognized by the marked shape of the cortex, the prominent white, opaque lamina dissecans and the radial 603 organization of the layers deep to the lamina dissecans. Layer II neurons are large spherical neurons, which differ 604 markedly in level of opacity from those in layer III. The medial border between MEC and parasubiculum is characterized 605 by the loss of the differentiation between layers II and III, and the border with the laterally adjacent postrhinal cortex 606 is characterized by the loss of the large spherical neurons in layer II [55] [56] [57] [58] [59] . We only sampled the more dorsal and 607 central portions of MEC. LEC shares the large layer II neurons with MEC, but the radial organization in layer V is absent. 608
The anterior and dorsal border of LEC with the perirhinal cortex is characterized by the abrupt disappearance of the 609 large layer II neurons. We only sampled the most lateral portions of LEC, as to avoid contamination with ventromedially 610 adjacent components of the amygdaloid complex. ACC and RSC were sampled from the medial wall of the lateral 611 hemisphere above the corpus callosum, avoiding the most anterior part of ACC and the posteroventral part of RCS. 612
Since the border between the two areas coincides with the dorsal-anterior tip of the hippocampal formation, all 613 samples avoided that border region. 614
In coronal sections, ACC and RSC samples were taken dorsal to the corpus callosum, just below the shoulder of the 615 medial wall of the hemisphere down to, but not touching the corpus callosum, as to avoid inclusion of the indusium 616 griseum. Samples were taken from sections anterior to the most anterodorsal tip of the hippocampal formation in 617 case of ACC and posterior to the tip in case of RSC. Samples of LEC were collected one section after the disappearance 618 of the piriform cortex characterized by a densely packed thick layer II, a polymorph lightly packed deeper cell layer 619 and the presence of the endopiriform nucleus. LEC shows cytoarchitectonic features similar to those described above. 620 We sampled only from the vertical part of LEC, directly below the rhinal fissure. For MEC, samples were collected from 621 more posterior coronal sections, using shape of the section, the presence of the ventral hippocampus and 622 cytoarchitectonic features as described above as our selection criteria. 623 Figure S1 . Example of microdissection, related to STAR methods and Figure 1 . Peak calls for each tissue type were used in the GREAT algorithm to assign genes. Ontology terms for these genes were ranked on Binominal P-value. Figure S3 . Injection construct, related to Figure 3 .
The putative enhancer of 0.7 to 3kbp was cloned to the injection construct by gateway® cloning. The synthetic intron, SV40, WPRE and growth hormone 1 exon 5 are present for optimal mRNA stability and expression of the tetracycline TransActivator (tTA). The construct is linearized with appropriate restriction enzymes depending on exact sequence of the putative enhancer. Sagittal sections of approximately similar levels. Different founders based on the same enhancers show roughly similar expression patterns. All mice based on MEC specific enhancers were crosses with hGFP reporter mice, while all mice based on LEC specific enhancers were crossed with GC6 payload mice. (A) Enhancer MEC-13-53 reproducibly shows expression in LII of the EC in 6 of the 7 analyzed mouse lines. We do find expression in other regions, such as visual cortex in founder B, the CA fields of the hippocampus in founder E, and deep layers of cortex in founder G. But since all of these patterns of expression occur only once within the 7 analyzed lines, we consider them to be positional effects. (B) Enhancer MEC-13-123 reproducibly shows expression in LIII of the EC, CA3 and select cortical layers. (C) Enhancer LEC-13-8 reproducibly shows expression in LIII of the EC. (D) Enhancer LEC-13-108 reproducibly shows expression in LII of the EC. We consider the additional expression in the "founder B" line to be another positional effect. Fluorescent signal of the mCherry conjugated to the tTA dependent gCaMP6 in sagittal sections (approximate level in mm lateral to midline indicated in white) show expression throughout the brain. The labeling of axons in the molecular layer in the dentate gyrus illustrates the transgenic labeling of layer II reelin+ cells.
